Table 1:
Baseline demographic and clinical data of patients enrolled in the PERMEATE Study.
| BASELINE CHARACTERISTICS | TOTAL (N = 29) |
|---|---|
| Mean age, years (SD) | 67.1 (9.7) |
| Male, n (%) | 18 (62.1) |
| Female, n (%) | 11 (37.9) |
| Race, n (%) | |
| Caucasian | 23 (79.3) |
| African-American | 6 (20.7) |
| Primary Diagnosis, n (%) | |
| DME | 14 (48.3) |
| Mild NPDR | 1 (7.1) |
| Moderate NPDR | 6 (42.9) |
| Severe NPDR | 4 (28.6) |
| PDR | 3 (21.4) |
| RVO | 15 (51.7) |
| CRVO | 10 (66.7) |
| BRVO | 5 (33.3) |
| Right study eye, n (%) | 17 (58.6) |
| Lens Status, n (%) | |
| Phakic | 22 (75.9) |
| Pseudophakic | 7 (24.1) |
| Glaucoma, n (%) | 9 (31) |
| Hypertension, n (%) | 23 (79.3) |
| Mean systolic pressure, mmHg | 147.6 |
| Mean diastolic pressure, mmHg | 83.4 |
DME: diabetic macular edema; NPDR: non-proliferative diabetic retinopathy; PDR: proliferative diabetic retinopathy; RVO: retinal vein occlusion; CRVO: central retinal vein occlusion; BRVO: branch retinal vein occlusion.